Navigation Links
Up to 20 million euros for Munich Catalysis research cooperation
Date:11/29/2010

Sd-Chemie AG and Technische Universitaet Muenchen (TUM) have formed a strategic alliance for catalysis research, "Munich Catalysis." In addition to basic research in the field of catalysis, a major aspect of this cooperation will be the development of innovative catalysts as a key technology to help meet the rising global demand for energy and base chemicals on a long-term basis. Sd-Chemie is to sponsor this research work with up to two million euros a year. The cooperation is based on a master agreement concluded for an initial term of ten years, which, if successful, is to be extended beyond this period.

Activities are due to start before the end of the year under the name "Munich Catalysis. Alliance of Sd-Chemie and TUM." Based on an industry-on-campus concept, TUM scientists will be working together with researchers from Sd-Chemie on central issues involving both basic and applied research in the field of chemical catalysis.

In addition to developing innovative catalysts and preparation methods, research will focus on identifying new ways of manufacturing basic chemicals, one of the key topics being the inert gas carbon dioxide. Among other things, the possibilities for efficiently separating this omnipresent so-called greenhouse gas from power plant processes and reusing it in chemical production cycles are to be explored, for instance as a synthesis module in the manufacture of energy sources or other base chemicals. Attention will also center on new ways of creating high-grade intermediate products for plastics, so-called olefins, without using oil.

Catalysis is seen as a vital technology for industrial materials conversion processes in the 21st century. Catalysts make it possible for most chemical products to be manufactured using low-energy and resource-sparing processes. They also play an essential role in promoting the targeted replacement of oil as a primary resource for the chemical industry by assisting in the manufacture of chemical products based on alternative resources, such as natural gas, coal or renewable (biogenic) raw materials.

This strategic cooperation will play an important role in the TUMs overall strategy of bundling university research activities in the field of chemical catalysis. The research alliance is to be integrated into a new central institute for catalysis research set up by the TUM (Catalysis Research Center, CRC). As from 2012, it will be housed in the new CRC building currently under construction on the TUM campus in Garching. The CRC bundles the TUMs broad scientific spectrum in the field of catalysis research with focus on industry-related research.

"The overriding goal envisaged by Munich Catalysis is to develop key catalytic technologies on a sustainable basis which in view of the limited fossil resources and a continuing rise in the global consumption of energy and base chemicals make the greatest demands on research alliances between university and industry," says the TUMs President, Professor Wolfgang A. Herrmann. "As an entrepreneurial university, our research activities pursue the path of innovation to the stage of technical realization. In the field of catalysis, we have selected Sd-Chemie since this partner has a globally successful catalyst business."

Upon signing the agreement, Dr. Gnter von Au, Managing Board Chairman of Sd-Chemie AG, said: "Chemical catalysis is a key technology and will be making a major contribution to the development of economically and ecologically sustainable ways of manufacturing fuel and chemicals in times when resources are in increasingly short supply. This pioneering venture is a means of bundling our numerous scientific cooperation projects with the TUM in the field of catalysis research based on a future-oriented and highly efficient industry-on-campus concept. In this way, we will continue to strengthen the TUMs academic base in this high-potential sector, while also achieving a sustained improvement in Sd-Chemies innovative strength."


'/>"/>

Contact: Dr. Andreas Battenberg
battenberg@zv.tum.de
49-892-891-0510
Technische Universitaet Muenchen
Source:Eurekalert  

Related biology news :

1. Researcher explores the evolution of largest mammals over the past 100 million years
2. $1.6 million to take forward breakthrough research in heart disease
3. NIH awards $10 million to advance microneedle patch for flu vaccination
4. Aeras awarded €11.7 million ($16 million) grant from Dutch government
5. $2.7 million research award to aid nursery, floriculture industry
6. New statistical model moves human evolution back 3 million years
7. Helmsley Charitable Trust awards more than $15 million to Salk Institute-CUMC
8. USAID awards $5 million to CONRAD
9. $12 million grant to probe root causes of heart failure
10. MegaMatcher Accelerator 3.0 for Rapid Biometric Identification Matches Up to 200 Million Irises or 100 Million Fingerprints Per Second
11. NIH renews Nanomedicine Center focused on treating single-gene disorders for $16.1 million
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Up to 20 million euros for Munich Catalysis research cooperation
(Date:3/30/2017)... 30, 2017  On April 6-7, 2017, Sequencing.com will ... hackathon at Microsoft,s headquarters in ... focus on developing health and wellness apps that provide ... the Genome is the first hackathon for personal ... largest companies in the genomics, tech and health industries ...
(Date:3/29/2017)... March 29, 2017  higi, the health IT company ... North America , today announced a Series ... acquisition of EveryMove. The new investment and acquisition accelerates ... tools to transform population health activities through the collection ... higi collects and secures data today on ...
(Date:3/24/2017)... 2017 The Controller General of Immigration from Maldives ... Algeen have received the prestigious international IAIR Award for the most ... Reading ... Maldives ... Abdulla Algeen (small picture on the right) have received the IAIR award ...
Breaking Biology News(10 mins):
(Date:6/14/2017)... ... June 14, 2017 , ... Cynvenio Biosystems, Inc. ... new distribution agreements for Cynvenio’s ClearID line of blood tests that support targeted treatment ... make ClearID available immediately in Israel, Greece, Argentina, and South Korea. , ...
(Date:6/14/2017)... ... June 14, 2017 , ... ... Phase 1 clinical study of AC0058, a novel irreversible Bruton’s Tyrosine Kinase ... autoimmune diseases, including rheumatoid arthritis and systemic lupus erythematosus. Fifty-six (56) ...
(Date:6/13/2017)... Philadelphia, PA (PRWEB) , ... June 13, 2017 ... ... from the University City Science Center’s Phase 1 Ventures (P1V) program. PolyCeramX, Recensa ... of technical development and commercialization activities. , Phase 1 Ventures is a ...
(Date:6/13/2017)... ... June 13, 2017 , ... Exxact ... research, today announced that it will offer the new NVIDIA® DGX Station™ and ... NVIDIA Volta™ architecture. , “NVIDIA’s DGX portfolio is paving the way for a ...
Breaking Biology Technology: